The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Safety and efficacy of durvalumab (MEDI4736), a PD-L1 antibody, in urothelial bladder cancer.
 
Christophe Massard
No Relationships to Disclose
 
Michael S. Gordon
Stock and Other Ownership Interests - Caremission; Medelis
Research Funding - Abbvie (Inst); Amgen (Inst); Array BioPharma (Inst); Genentech/Roche (Inst); Gilead Sciences (Inst); GlaxoSmithKline (Inst); Incyte (Inst); Lilly (Inst); Lilly/ImClone (Inst); MedImmune (Inst); Merck Serono (Inst); Millennium (Inst); OncoMed (Inst); Pfizer (Inst); Sirtex Medical (Inst)
 
Sunil Sharma
Stock and Other Ownership Interests - Beta Cat Pharmaceuticals; ConverGene; Salarius Pharmaceuticals
Honoraria - Blend Therapeutics; Novartis; Novartis; Novartis
Consulting or Advisory Role - Blend Therapeutics; Novartis; Novartis; Novartis
Research Funding - Amgen (Inst); Bayer (Inst); Blueprint Medicines (Inst); Celgene (Inst); Gilead Sciences (Inst); GlaxoSmithKline (Inst); Incyte (Inst); Johnson & Johnson (Inst); Labceutics (Inst); MedImmune (Inst); Merck (Inst); Merrimack (Inst); Millennium (Inst); Mirati Therapeutics (Inst); Novartis (Inst); Onyx (Inst); Plexxikon (Inst); Sanofi (Inst); Spectrum Pharmaceuticals (Inst); XuanZhu (Inst)
Patents, Royalties, Other Intellectual Property - Patent Pending: "Substituted N-Phenylpyrimidin-2-Amine Analogs as Inhibitors of the AXL Kinase". U.S. Patent No. WO 2012135800 A1 20121004. Washington, D.C.:U.S. Patent and Trademark Office.; Patent: "Substituted 3-(IH-Benzo[D]Imidazol-2-YL)-IH-Indazole Analogs as Inhibitors of the PDKI Kinase". U.S. Patent No. WO 2012135799 A1 20121004. Washington, D.C.:U.S. Patent and Trademark Office.; Patent: "Substituted N-(3-(Pyrimidin-4-YL)Phenyl)Acrylamide Analogs as Tyrosine Receptor Kinase BTK Inhibitors". U.S. Patent No. US 8,703,767 B2. Washington, D.C.:U.S. Patent and Trademark Office.
Travel, Accommodations, Expenses - Clovis Oncology; Novartis; Novartis; Novartis
 
Saeed Rafii
No Relationships to Disclose
 
Zev A. Wainberg
Consulting or Advisory Role - Sirtex Medical; Taiho Pharmaceutical
Speakers' Bureau - Genentech
Research Funding - Biomarin (Inst); Novartis (Inst); Pfizer (Inst); Plexxikon (Inst)
Travel, Accommodations, Expenses - Genentech; Lilly
 
Jason John Luke
Honoraria - Intellisphere, LLC
Consulting or Advisory Role - Amgen; Array BioPharma
Research Funding - Boston Biomedical; Bristol-Myers Squibb; EMD Serono; GlaxoSmithKline; Incyte; MedImmune; Merck; Novartis
Travel, Accommodations, Expenses - Amgen; Array BioPharma; Bayer; Bristol-Myers Squibb; Genentech
 
Tyler J. Curiel
Stock and Other Ownership Interests - Amgen; Biogen; Celgene
Honoraria - Eisai
Consulting or Advisory Role - Eisai
Research Funding - Compugen
Patents, Royalties, Other Intellectual Property - Mapk inhibitors in parasite infections
Travel, Accommodations, Expenses - Eisai
 
Gerardo Colon-Otero
Research Funding - Novartis (Inst)
 
Omid Hamid
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Novartis; Roche
Speakers' Bureau - Bristol-Myers Squibb; Genentech; Novartis
Research Funding - AstraZeneca; Bristol-Myers Squibb; Celldex; Genentech; Immunocore; Incyte; MedImmune; Merck; Merck Serono; Novartis; Pfizer; Rinat; Roche
 
Rachel E. Sanborn
Consulting or Advisory Role - Amgen
Research Funding - Bristol-Myers Squibb (Inst); MedImmune (Inst)
 
Peter H. O'Donnell
Stock and Other Ownership Interests - Davita
Honoraria - Algeta ASA; American Medical Forum; Dendreon; Genentech/Roche; Novartis; OptumHealth
Research Funding - Boehringer Ingelheim (Inst)
Patents, Royalties, Other Intellectual Property - Named as co-inventor on a pending patent for a genomic prescribing system for medication prescribing.
Travel, Accommodations, Expenses - Sequenom
Other Relationship - Advance Medical
 
Alexandra Drakaki
No Relationships to Disclose
 
John Kurland
Employment - AstraZeneca/MedImmune; Bristol-Myers Squibb
Stock and Other Ownership Interests - AstraZeneca/MedImmune; Bristol-Myers Squibb
 
Marlon C. Rebelatto
Employment - AstraZeneca/MedImmune
Stock and Other Ownership Interests - AstraZeneca
Patents, Royalties, Other Intellectual Property - AstraZeneca/MedImmune
Travel, Accommodations, Expenses - AstraZeneca/MedImmune
 
Xiaoping Jin
Employment - MedImmune; MedImmune (I); UnitedHealthcare; UnitedHealthcare (I)
Stock and Other Ownership Interests - AstraZeneca; AstraZeneca (I); UnitedHealthcare; UnitedHealthcare (I)
 
John A. Blake-Haskins
Employment - AstraZeneca/MedImmune; AstraZeneca/MedImmune (I)
Stock and Other Ownership Interests - AstraZeneca/MedImmune; AstraZeneca/MedImmune (I)
 
Ashok Kumar Gupta
Employment - MedImmune
 
Neil Howard Segal
Honoraria - MedImmune
Consulting or Advisory Role - AstraZeneca/MedImmune; Bristol-Myers Squibb; Imugene; Kyocera; Macrogenics; Pfizer; Roche/Genentech
Research Funding - Bristol-Myers Squibb; MedImmune; Merck; Pfizer; Roche/Genentech